BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26997698)

  • 1. Effect of Different Polymer Concentration on Drug Release Rate and Physicochemical Properties of Mucoadhesive Gastroretentive Tablets.
    Agarwal S; Murthy RS
    Indian J Pharm Sci; 2015; 77(6):705-14. PubMed ID: 26997698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac.
    Koirala S; Nepal P; Ghimire G; Basnet R; Rawat I; Dahal A; Pandey J; Parajuli-Baral K
    Heliyon; 2021 Mar; 7(3):e06439. PubMed ID: 33786387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of gastroretentive mucoadhesive cephalexin tablets.
    Sonani NG; Hiremath SP; Dasankoppa FS; Jamakandi VG; Sreenivas SA
    Pharm Dev Technol; 2010; 15(2):178-83. PubMed ID: 19586492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between mucoadhesive polymers and surface coating in tablets for the controlled colonic delivery of a poorly water-soluble drug.
    Phan TQ; Tran PHL; Tran TTD
    Daru; 2020 Dec; 28(2):545-553. PubMed ID: 32705542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.
    Tamilvanan S; Bangale GS; Ananthi JJ; Sivakumar V; Vinothapooshan G; Palanivelu M; Viswanathan MB
    PDA J Pharm Sci Technol; 2009; 63(3):196-206. PubMed ID: 20069792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization of chitosan/methylcellulose interpenetrating polymer network microspheres for gastroretentive application using central composite design.
    Kumar P; Bhatia M
    PDA J Pharm Sci Technol; 2010; 64(6):497-506. PubMed ID: 21502060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive tablets for controlled release of acyclovir.
    Ruiz-Caro R; Gago-Guillan M; Otero-Espinar FJ; Veiga MD
    Chem Pharm Bull (Tokyo); 2012; 60(10):1249-57. PubMed ID: 22863800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol Hydrochloride Buccoadhesive Tablet: Development and
    Mortazavi SM; Mortazavi SA
    Iran J Pharm Res; 2020; 19(2):22-33. PubMed ID: 33224208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of gastroretentive norfloxacin floating tablets.
    Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
    Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.
    Kassem MA; Elmeshad AN; Fares AR
    Int J Pharm; 2014 Mar; 463(1):68-80. PubMed ID: 24412520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
    Srivastava AK; Wadhwa S; Ridhurkar D; Mishra B
    Drug Dev Ind Pharm; 2005 May; 31(4-5):367-74. PubMed ID: 16093202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of mucoadhesive vaginal tablets of tenofovir disoproxil fumarate for pre-exposure prophylaxis of HIV.
    Khan AB; Thakur RS
    Drug Dev Ind Pharm; 2018 Mar; 44(3):472-483. PubMed ID: 29082767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M; Sri Nataraj K; Ganesh KS
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
    Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.
    Sankar R; Jain SK
    Drug Des Devel Ther; 2013; 7():1455-69. PubMed ID: 24348022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preformulation studies of mucoadhesive tablets for carbamazepine sublingual administration.
    Perioli L; Pagano C
    Colloids Surf B Biointerfaces; 2013 Feb; 102():915-22. PubMed ID: 23124021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S; Talele GS
    Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on formulation and in vitro evaluation of floating matrix tablets of domperidone.
    Prajapati ST; Patel LD; Patel DM
    Indian J Pharm Sci; 2009 Jan; 71(1):19-23. PubMed ID: 20177450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of omeprazole tablets for duodenal ulcer.
    Choudhury A; Das S; Bahadur S; Saha S; Roy A
    Indian J Pharm Sci; 2010 Jul; 72(4):491-4. PubMed ID: 21218061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the source and the concentration of polymers on the release of chlorhexidine from mucoadhesive buccal tablets.
    Al-Ani E; Martin C; Britland ST; Doudin K; Hill DJ
    Saudi Pharm J; 2019 Sep; 27(6):756-766. PubMed ID: 31516318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.